Literature DB >> 35814605

Safety of Conservative Management of High-Grade Squamous Intraepithelial Lesion in Women Under 30 Years Old.

Mariana K Bonas1, Michelle G Discacciati1, Hisa M Videira1, Lucas A Cavalcante1, Julio C Teixeira1, Diama B Vale1.   

Abstract

Objectives: To evaluate the outcomes of conservative management in young women with high-grade squamous intraepithelial lesion (HSIL).
Methods: A retrospective cohort study included women younger than 30 years referred with HSIL (cytology or biopsy) managed conservatively from 2012 to 2019, in Campinas/Brazil. Regression was the outcome when no evidence of HSIL was observed in at least two consecutive follow-ups. Kaplan-Meyer method was used to determine regression probabilities. Other tests were chi-square or Fisher, Mann-Whitney and COX regression.
Results: During the study period, 89 patients were included. No progression to microinvasive or invasive cancer was observed. Sixty-one (69%) patients were younger than 25 years, and 28 (31%) were aged 25-30 years. Spontaneous regression was seen in 64 (72%) and persistence in 25 (28%) of the overall sample. The average time to regression was 15.4 months (standard deviation [SD] = 7.7), and the follow-up time was 31.6 months (SD 19.0). Age, parity, first sexual intercourse, smoking, hormonal contraception, and colposcopy impression were not different among women with regression or persistence. Regression probabilities were, respectively, 28.9%, 60.2%, and 78.1% after 12, 18, and 24 months. Most of the events happened between 12 and 18 months of follow-up. Conclusions: Conservative management in women younger than 30 years was safe: spontaneous regression was observed in 72% of all women younger than 30 with HSIL managed conservatively. No clinical variable was relevant, influencing regression. In 2 years the regression probability was 78%. © Mariana K. Bonas et al., 2022; Published by Mary Ann Liebert, Inc.

Entities:  

Keywords:  cervical intraepithelial neoplasia; conservative treatment; papillomavirus infections; secondary prevention; uterine cervical neoplasms; young adult

Year:  2022        PMID: 35814605      PMCID: PMC9258792          DOI: 10.1089/whr.2022.0024

Source DB:  PubMed          Journal:  Womens Health Rep (New Rochelle)        ISSN: 2688-4844


  25 in total

Review 1.  Cytology versus HPV testing for cervical cancer screening in the general population.

Authors:  George Koliopoulos; Victoria N Nyaga; Nancy Santesso; Andrew Bryant; Pierre Pl Martin-Hirsch; Reem A Mustafa; Holger Schünemann; Evangelos Paraskevaidis; Marc Arbyn
Journal:  Cochrane Database Syst Rev       Date:  2017-08-10

2.  Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2).

Authors:  Jean-Luc Brun; Déborah Letoffet; Marion Marty; Romain Griffier; Xavier Ah-Kit; Isabelle Garrigue
Journal:  Arch Gynecol Obstet       Date:  2020-11-11       Impact factor: 2.344

3.  Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.

Authors:  Kieran Dempster-Rivett; Carrie R Innes; Bryony J Simcock; Dianne Harker; Jonathan A Williman; Rachael A Van Der Griend; Martin Whitehead; Merilyn Hibma; Beverley A Lawton; Peter Fitzgerald; Narena M Dudley; Simone Petrich; Jim Faherty; Cecile Bergzoll; Lois Eva; Lynn Sadler; Selvan Pather; C David Wrede; Peter H Sykes
Journal:  Am J Obstet Gynecol       Date:  2020-02-25       Impact factor: 8.661

4.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

5.  Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.

Authors:  Carla Fabrine Carvalho; Julio Cesar Teixeira; Joana Froes Bragança; Sophie Derchain; Luiz Carlos Zeferino; Diama Bhadra Vale
Journal:  Rev Bras Ginecol Obstet       Date:  2022-02-15

6.  2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Authors:  Rebecca B Perkins; Richard S Guido; Philip E Castle; David Chelmow; Mark H Einstein; Francisco Garcia; Warner K Huh; Jane J Kim; Anna-Barbara Moscicki; Ritu Nayar; Mona Saraiya; George F Sawaya; Nicolas Wentzensen; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 1.925

7.  Cervical screening in under 25s: a high-risk young population.

Authors:  F Bano; S Kolhe; D Zamblera; A Jolaoso; O Folayan; L Page; J Norton
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-10-29       Impact factor: 2.435

8.  High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.

Authors:  Diama B Vale; Maria C Westin; Luiz C Zeferino
Journal:  Cancer Cytopathol       Date:  2013-06-13       Impact factor: 5.284

9.  Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study.

Authors:  Julien Chevreau; Antonin Mercuzot; Arthur Foulon; Chirstophe Attencourt; Fabrice Sergent; Ségolène Lanta; Jean Gondry
Journal:  J Low Genit Tract Dis       Date:  2017-04       Impact factor: 1.925

10.  Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Didem Egemen; Li C Cheung; Xiaojian Chen; Maria Demarco; Rebecca B Perkins; Walter Kinney; Nancy Poitras; Brian Befano; Alexander Locke; Richard S Guido; Amy L Wiser; Julia C Gage; Hormuzd A Katki; Nicolas Wentzensen; Philip E Castle; Mark Schiffman; Thomas S Lorey
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.